MiniMed Expands European Sensor Options with Abbott's Instinct Sensors
Event summary
- MiniMed launched Instinct and Instinct Go sensors in Europe, expanding its sensor portfolio.
- The sensors, made by Abbott, are the smallest, longest-wear options in Abbott's portfolio.
- MiniMed™ 780G system with Instinct sensor achieved glycemic outcomes identical to Simplera Sync™ sensor.
- MiniMed Go™ system integrates InPen™ smart insulin pen with real-time CGM data for MDI users.
The big picture
MiniMed's expansion of its sensor portfolio in Europe with Abbott's Instinct sensors underscores the strategic importance of partnerships in the diabetes technology sector. This move aligns with broader industry trends toward integrated, patient-centric solutions that combine insulin delivery systems with advanced continuous glucose monitoring (CGM) technologies. The ability to offer multiple sensor options enhances MiniMed's competitive position, particularly as it seeks to maintain leadership in automated insulin delivery systems.
What we're watching
- Market Penetration
- How MiniMed will leverage Abbott's sensor technology to gain market share in Europe.
- Clinical Performance
- Whether the integration of Instinct sensors will maintain or improve glycemic outcomes for users.
- Competitive Dynamics
- The pace at which competitors like Dexcom and Medtronic respond with their own sensor integrations.
Related topics